Home LiteratureArticle Details
PMID: 9205945 Published · ppublish English Journal Article Review

The Fas counterattack: a molecular mechanism of tumor immune privilege.

Molecular medicine (Cambridge, Mass.) ·Vol. 3 ·No. 5 ·1997-05-00 ·Pages 294-300

O'Connell J, Bennett MW, O'Sullivan GC, Collins JK, Shanahan F

Abstract

暂无摘要

MeSH Terms
Animals Apoptosis Humans Neoplasms/immunology,therapy Oligonucleotides, Antisense/therapeutic use Tumor Escape/immunology fas Receptor/drug effects,immunology
Chemicals
Oligonucleotides, Antisense fas Receptor
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
O'Connell J
Department of Medicine, National University of Ireland, Cork, Ireland.
Bennett M W
O'Sullivan G C
Collins J K
Shanahan F
References (72)
72 references, click to expand
  1. The Fas death factor.
    Science. 1995 Mar 10;267(5203):1449-56 PMID: 7533326
  2. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias.
    Blood. 1995 Mar 15;85(6):1562-9 PMID: 7534137
  3. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis.
    Int J Cancer. 1995 Mar 16;60(6):854-9 PMID: 7896458
  4. Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes.
    Int Immunol. 1994 Dec;6(12):1849-56 PMID: 7535095
  5. Expression of the Fas ligand in cells of T cell lineage.
    J Immunol. 1995 Apr 15;154(8):3806-13 PMID: 7706720
  6. FAP-1: a protein tyrosine phosphatase that associates with Fas.
    Science. 1995 Apr 21;268(5209):411-5 PMID: 7536343
  7. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?
    Nat Med. 1996 Dec;2(12):1361-6 PMID: 8946836
  8. Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line.
    Biochem Biophys Res Commun. 1996 Dec 4;229(1):21-6 PMID: 8954078
  9. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression.
    Diabetes. 1997 Feb;46(2):317-22 PMID: 9000711
  10. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
    J Clin Invest. 1997 Feb 1;99(3):396-402 PMID: 9022072
  11. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.
    J Clin Invest. 1997 Feb 1;99(3):403-13 PMID: 9022073
  12. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
    J Exp Med. 1996 Sep 1;184(3):1075-82 PMID: 9064324
  13. Lethal effect of the anti-Fas antibody in mice.
    Nature. 1993 Aug 26;364(6440):806-9 PMID: 7689176
  14. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
    J Immunol. 1994 Feb 1;152(3):1127-33 PMID: 7507960
  15. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.
    Cancer Res. 1994 Mar 15;54(6):1580-6 PMID: 7511047
  16. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium.
    Int J Cancer. 1994 May 1;57(3):371-7 PMID: 8168998
  17. Expression of functional Fas antigen on adult T-cell leukemia.
    Leuk Res. 1994 Apr;18(4):305-10 PMID: 7513372
  18. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice.
    J Exp Med. 1996 Sep 1;184(3):1149-54 PMID: 9064331
  19. The CTL's kiss of death.
    Cell. 1995 Apr 7;81(1):9-12 PMID: 7536631
  20. Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis.
    Blood. 1995 Feb 1;85(3):757-64 PMID: 7530506
  21. Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis.
    Immunity. 1995 Apr;2(4):353-62 PMID: 7536621
  22. Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer.
    Cancer. 1985 Mar 15;55(6):1327-33 PMID: 3871657
  23. Monoclonal antibody-mediated tumor regression by induction of apoptosis.
    Science. 1989 Jul 21;245(4915):301-5 PMID: 2787530
  24. Effect of bcl-2 on Fas antigen-mediated cell death.
    J Immunol. 1993 Jul 15;151(2):621-7 PMID: 7687619
  25. Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells.
    Proc Natl Acad Sci U S A. 1994 May 10;91(10):4185-9 PMID: 7514297
  26. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.
    J Immunol. 1994 Jun 15;152(12):5624-32 PMID: 7515909
  27. Apoptotic cell death induced by a mouse-human anti-APO-1 chimeric antibody leads to tumor regression.
    Int J Cancer. 1994 Aug 15;58(4):562-7 PMID: 7520027
  28. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
    J Clin Invest. 1994 Sep;94(3):954-64 PMID: 7521890
  29. APO-1 (CD95) mediated apoptosis in human T-ALL engrafted in SCID mice.
    Leukemia. 1994 Nov;8(11):1825-33 PMID: 7526086
  30. Fas ligand mediates activation-induced cell death in human T lymphocytes.
    J Exp Med. 1995 Jan 1;181(1):71-7 PMID: 7528780
  31. Granzyme A is an interleukin 1 beta-converting enzyme.
    J Exp Med. 1995 May 1;181(5):1917-22 PMID: 7722467
  32. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis.
    Nature. 1995 May 4;375(6526):81-3 PMID: 7536901
  33. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A.
    J Biol Chem. 1995 May 5;270(18):10377-9 PMID: 7737968
  34. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.
    Cell. 1995 May 19;81(4):505-12 PMID: 7538907
  35. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.
    Cell. 1995 May 19;81(4):513-23 PMID: 7538908
  36. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression.
    Mol Cell Biol. 1995 Jun;15(6):3032-40 PMID: 7539102
  37. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
    J Clin Invest. 1995 Jun;95(6):2633-43 PMID: 7539458
  38. Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines.
    Blood. 1995 Jun 15;85(12):3566-76 PMID: 7540067
  39. Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients.
    Blood. 1995 Jun 15;85(12):3679-87 PMID: 7540069
  40. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells.
    Oncogene. 1995 Jun 15;10(12):2297-305 PMID: 7540278
  41. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.
    Oncogene. 1995 Jun 15;10(12):2397-401 PMID: 7784089
  42. Fas/APO-1 gene transfer for human malignant glioma.
    Cancer Res. 1995 Jul 1;55(13):2936-44 PMID: 7540953
  43. Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?
    Cancer Lett. 1995 Jul 20;94(1):1-8 PMID: 7542559
  44. Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders.
    Blood. 1995 Sep 1;86(5):1939-45 PMID: 7544648
  45. Regulation of the Fas apoptotic cell death pathway by Abl.
    J Biol Chem. 1995 Sep 22;270(38):22625-31 PMID: 7545682
  46. Bcl-XL protects cancer cells from p53-mediated apoptosis.
    Oncogene. 1995 Oct 5;11(7):1389-94 PMID: 7478561
  47. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen.
    J Immunol. 1995 Nov 1;155(9):4147-54 PMID: 7594569
  48. A role for CD95 ligand in preventing graft rejection.
    Nature. 1995 Oct 19;377(6550):630-2 PMID: 7566174
  49. Resistance to Fas-mediated apoptosis in human hepatoma cells.
    Oncogene. 1995 Sep 21;11(6):1157-64 PMID: 7566976
  50. Fas ligand-induced apoptosis as a mechanism of immune privilege.
    Science. 1995 Nov 17;270(5239):1189-92 PMID: 7502042
  51. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.
    Oncogene. 1995 Nov 16;11(10):1939-46 PMID: 7478511
  52. Expression of Fas/APO-1 during the progression of astrocytomas.
    Cancer Res. 1995 Dec 1;55(23):5528-30 PMID: 7585627
  53. A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis.
    Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11894-8 PMID: 8524870
  54. Fas involvement in cytotoxicity mediated by human NK cells.
    Cell Immunol. 1995 Dec;166(2):236-46 PMID: 7497525
  55. Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells.
    Cancer Res. 1995 Dec 15;55(24):6166-71 PMID: 8521409
  56. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
    J Immunol. 1996 Jan 1;156(1):13-7 PMID: 8598453
  57. Regulation of Fas(Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2.
    Eur J Immunol. 1995 Dec;25(12):3509-13 PMID: 8566045
  58. Activated B cells express functional Fas ligand.
    Eur J Immunol. 1996 Mar;26(3):721-4 PMID: 8605944
  59. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis.
    Cancer Res. 1996 Apr 15;56(8):1874-9 PMID: 8620507
  60. Fas ligand in human serum.
    Nat Med. 1996 Mar;2(3):317-22 PMID: 8612231
  61. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis.
    Nature. 1996 Apr 25;380(6576):723-6 PMID: 8614469
  62. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.
    Nat Med. 1996 May;2(5):574-7 PMID: 8616718
  63. Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines.
    J Exp Med. 1996 Mar 1;183(3):867-78 PMID: 8642291
  64. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
    J Clin Invest. 1996 Jun 1;97(11):2651-9 PMID: 8647960
  65. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice.
    Science. 1996 Jul 5;273(5271):109-12 PMID: 8658177
  66. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.
    Cell. 1996 Jun 14;85(6):817-27 PMID: 8681377
  67. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.
    J Exp Med. 1996 Aug 1;184(2):429-40 PMID: 8760796
  68. Fas expression and function in normal and malignant breast cell lines.
    Cancer Res. 1996 Oct 15;56(20):4791-8 PMID: 8841000
  69. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin.
    J Immunol. 1996 Nov 15;157(10):4277-81 PMID: 8906799
  70. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
    Science. 1996 Nov 22;274(5291):1363-6 PMID: 8910274
  71. Decreased tumor surveillance in perforin-deficient mice.
    J Exp Med. 1996 Nov 1;184(5):1781-90 PMID: 8920866
  72. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death.
    J Exp Med. 1996 Nov 1;184(5):2067-72 PMID: 8920897
Article Info
Journal
Molecular medicine (Cambridge, Mass.)
Abbr.
Mol Med
ISSN
1076-1551
Published
1997-05-00
Pages
294-300
Language
English
Region
England
NLM ID
9501023
PMCID
PMC2230082
Subset
IM
External Links
PubMed source PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2